Rare Cancers: Spotlight on Precision Oncology

Explore groundbreaking developments in the diagnosis and treatment of rare cancers like sarcomas, NETs, and rare lymphomas at the Paris Congress. Sessions focus on molecular profiling, immunotherapy, and biomarker-driven precision oncology. Hear from oncologists, researchers, and survivors discussing targeted therapies, early detection strategies, and supportive care advancements. Gain insights into how global cancer networks and rare tumor registries are reshaping research and clinical pathways. Don’t miss this essential dialogue on improving outcomes and equity for patients facing rare and aggressive cancers.

    Related Conference of Rare Cancers: Spotlight on Precision Oncology

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Rare Cancers: Spotlight on Precision Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in